Company
United StatesPublic company, NYSE: TAKTakeda Pharmaceutical Company Limited (NYSE: TAK), Round Lake, IL – FDA Inspections
Inspection records and compliance data for Takeda Pharmaceutical Company Limited in Round Lake, Illinois. 3 FDA inspections on record, 2 Form 483s, last inspected November 26, 2025. Publicly traded as NYSE: TAK.
Company Profile
This profile covers Takeda Pharmaceutical Company Limited based in Round Lake, Illinois, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 2
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 2
- Warning letters
- 0
First inspected September 25, 2019. Last inspected November 26, 2025.
Most cited issue areas
- Absence of Written Procedures1 inspection
- Corrective action record review adequacy1 inspection
- Initial registration and listing1 inspection
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| November 26, 2025 | Not classified | Biologics · Blood and Blood Products | 1293098 |
| September 15, 2022 | VAI | Biologics · Blood and Blood Products | 1179911 |
| September 25, 2019 | VAI | Biologics · Blood and Blood Products | 1103189 |
FDA documents
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Takeda Pharmaceutical Company Limited
Stock ticker
TAK
Exchange
NYSE
Share price
$21.13
Market cap
$66.8B
Price as of
November 13, 2026
FEI Number
3012385969
Address
25212 W Il Route 120, Round Lake, Illinois 60073, United States
Country
United States
ID: 4611dabc-52f7-4b4a-96bf-4196e34a7c2b